HIGHLIGHTS
- who: Juan Luis Rodru00edguez Hermosa and collaborators from the Pulmonology Department, Research Institute of Hospital Clu00ednico San Carlos (IdISSC), Madrid, Spain Department of Medicine, Faculty of Medicine, Complutense University of Madrid, Madrid, Spain have published the research work: Severe COVID-19 Illness and 1-Antitrypsin Deficiency: COVID-AATD Study, in the Journal: Biomedicines 2023, 11, x FOR PEER REVIEW of 10/02/2023
- what: The authors focused on the possible role of AATD as a risk factor for severe COVID19 progression. The authors examined the presence of genetic mutations associated with AATD and A1AT levels . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.